Cambridge Investment Research Advisors’s Allergan plc AGN.PRA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-388	Closed	-$227K	–	2287
2017 Q4	$227K	Sell	388 -27	-7%	-$17.4K	﹤0.01%	1838
2017 Q3	$306K	Sell	415 -40	-9%	-$33.2K	﹤0.01%	1542
2017 Q2	$395K	Sell	455 -45	-9%	-$37.7K	0.01%	1350
2017 Q1	$424K	Sell	500 -46	-8%	-$38.1K	0.01%	1159
2016 Q4	$416K	Buy	546 +24	+5%	+$18.1K	0.01%	1106
2016 Q3	$429K	Sell	522 -36	-6%	-$31.1K	0.01%	1118
2016 Q2	$465K	Sell	558 -14	-2%	-$11.7K	0.01%	962
2016 Q1	$526K	Buy	572 +55	+11%	+$52.6K	0.01%	867
2015 Q4	$532K	Buy	517 +46	+10%	+$46.2K	0.01%	828
2015 Q3	$444K	Buy	+471	New	+$491K	0.01%	819

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Cambridge Investment Research Advisors's AGN.PRA Position: Q1 2018 in Review

Cambridge Investment Research Advisors sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 388 shares — an estimated $227K sold.

Cambridge Investment Research Advisors first reported a position in AGN.PRA in Q3 2015 and held it in 10 quarters. The position peaked at $532K in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Cambridge Investment Research Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Cambridge Investment Research Advisors sold 388 Allergan plc shares in Q1 2018, an estimated $227K.
Cambridge Investment Research Advisors first reported a position in Allergan plc in Q3 2015 and held it in 10 quarters.
Cambridge Investment Research Advisors's Allergan plc position peaked at $532K in Q4 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.